Precigen, Inc.
PGEN
$4.15
$0.071.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.62M | 2.92M | 822.00K | 1.32M | 1.21M |
| Total Other Revenue | -57.00K | -- | 34.00K | 23.00K | -22.00K |
| Total Revenue | 4.57M | 2.92M | 856.00K | 1.34M | 1.19M |
| Cost of Revenue | 8.59M | 13.41M | 1.56M | 1.10M | 12.93M |
| Gross Profit | -4.02M | -10.49M | -699.00K | 241.00K | -11.74M |
| SG&A Expenses | 17.65M | 23.99M | 16.13M | 12.36M | 11.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.23M | 37.40M | 28.71M | 23.94M | 23.93M |
| Operating Income | -21.67M | -34.48M | -27.86M | -22.60M | -22.74M |
| Income Before Tax | -23.50M | -146.34M | -26.64M | -54.15M | -19.81M |
| Income Tax Expenses | 0.00 | -- | 3.00K | -- | -87.00K |
| Earnings from Continuing Operations | -23.50M | -146.34M | -26.64M | -54.15M | -19.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.50M | -146.34M | -26.64M | -54.15M | -19.73M |
| EBIT | -21.67M | -34.48M | -27.86M | -22.60M | -22.74M |
| EBITDA | -20.53M | -33.68M | -27.23M | -21.97M | -22.08M |
| EPS Basic | -0.07 | -1.06 | -0.09 | -0.18 | -0.07 |
| Normalized Basic EPS | -0.04 | -0.30 | -0.05 | -0.12 | -0.05 |
| EPS Diluted | -0.07 | -1.06 | -0.09 | -0.18 | -0.07 |
| Normalized Diluted EPS | -0.04 | -0.30 | -0.05 | -0.12 | -0.05 |
| Average Basic Shares Outstanding | 354.29M | 307.17M | 296.43M | 293.88M | 293.15M |
| Average Diluted Shares Outstanding | 354.29M | 307.17M | 296.43M | 293.88M | 293.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |